Quantum Biopharma Ltd (QNTM) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma

Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma PR Newswire NEW YORK...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

The Quantum Group, Inc. Announces Former IBM Executive P.L. 'Pete' Martinez Has Joined the Company

Named Vice President, Chief Technology & Innovations Officer WELLINGTON, Fla., June 25 /PRNewswire-FirstCall/ -- The Quantum Group, Inc...

The Quantum Group, Inc. Announces Additions to the Board of Directors

Announces AMEX Application and Sets Date for Annual Shareholders Meeting WELLINGTON, Fla., June 14 /PRNewswire-FirstCall/ -- The Quantum Group...